Articles From: OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE to OptimumBank Appoints Norman J. Ginsparg as Director


OPKO Health, Inc. (NYSE:OPK), a multinational biopharmaceutical and diagnostics company, today announced that the United States Patent and Trademark Office granted OPKO a patent covering RAYALDEE ™, the Company’s product to treat secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.
Sign-up for OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE investment picks
OPKO Health, Inc. (NYSE:OPK) today announced the European launch of the 4Kscore ™ Test, the only blood test that accurately identifies risk for aggressive prostate cancer, through its wholly owned subsidiary, OPKO Health Spain.
Sign-up for OPKO Launches the 4Kscore Test in Europe investment picks
OPKO Health, Inc. (NYSE:OPK), reported that its licensee, TESARO, Inc. (Nasdaq:TSRO), has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for approval of oral rolapitant, an investigational neurokinin-1 (NK-1) receptor antagonist in development for the prevention of chemotherapy-induced nausea and vomiting (CINV). This NDA is supported by data from four controlled studies covering a spectrum of patients receiving chemotherapy that commonly causes nausea and vomiting.
Sign-up for OPKO Licensee TESARO Submits New Drug Application for Rolapitant investment picks
OPKO Health, Inc. (NYSE: OPK), announced the submission of an Investigational New Drug (IND) Application to the United States (U.S.) Food and Drug Administration (FDA) under which Rayaldee ™ will begin clinical evaluation as an adjunctive therapy for the prevention of skeletal-related events (SREs) in patients with bone metastases undergoing anti-resorptive therapy.
Sign-up for OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy investment picks
OPKO Health, Inc. (NYSE: OPK ) will announce top line data from the first of two identical pivotal Phase 3 clinical trials for RAYALDEE™ and its second-quarter 2014 financial results on Monday, August 11, 2014, after the market closes.
Sign-up for OPKO to Announce Top Line RAYALDEE Results and Second Quarter 2014 Financial Results on August 11, 2014 investment picks
OPKO Health, Inc. (NYSE: OPK), a multinational biopharmaceutical and diagnostics company that is developing a novel long-acting human growth hormone product (hGH-CTP) for the treatment of growth hormone deficiency (GHD), today announced it will hold a conference call and webcast on Tuesday, June 24, 2014 at 8:30 a.m. EDT (7:30 a.m. CDT). During the call, OPKO Biologics management will discuss data from the company's advanced phase 2 trial of hGH-CTP in growth hormone deficient pediatric subjects.
Sign-up for OPKO to Hold Conference Call to Discuss Six Month Data from Phase 2 hGH-CTP Trial investment picks
OPKO Health, Inc. (NYSE:OPK) today announced that the European Committee for Orphan Medicinal Products (COMP) gave a positive opinion recommending the approval of orphan drug designation for OPKO's long-acting version of clotting Factor VIIa (Factor VIIa-CTP) for the treatment of bleeding episodes in patients with hemophilia A or B with inhibitors to Factor VIII or Factor IX and congenital Factor VII deficiency.
Sign-up for OPKO's Long-Acting Clotting Factor VIIa-CTP Receives Positive Opinion For Three Orphan Drug Designations in Europe investment picks
Commences Process to Evaluate Strategic Alternatives for Oplink Connected Business, Including Possible Sale FREMONT, Calif., July 29, 2014 (GLOBE NEWSWIRE) -- Oplink Communications, Inc. (Nasdaq:OPLK) , a leading provider of optical communication components, intelligent modules and subsystems, today announced a series of initiatives to further enhance shareholder value.
Sign-up for Oplink Announces Initiatives to Enhance Shareholder Value investment picks
FREMONT, Calif., Aug.
Sign-up for Oplink Reports Fourth Quarter and Fiscal Year 2014 Financial Results investment picks
Oplink Shareholders for Change (“OSC”), a group led by Engaged Capital, LLC (“Engaged Capital”) and Voce Capital Management LLC (“Voce Capital”), who collectively own approximately 6.2% of the outstanding shares of Oplink Communications Inc. (“Oplink” or the “Company”) (NASDAQ:OPLK), called on the board of directors of Oplink (the “Board”) to suspend its strategic decision-making process until the reconstitution of the Board at the upcoming annual meeting of shareholders (the “Annual Meeting”). In light of OSC’s nomination of two independent, highly-qualified director candidates, Jeffrey S.
Sign-up for Oplink Shareholders For Change (OSC) Call on Oplink Board to Respect Shareholder Democracy and Allow New Board to Set Strategy investment picks
Oplink Shareholders for Change (“OSC”), a group led by Engaged Capital, LLC (“Engaged Capital”) and Voce Capital Management LLC (“Voce Capital”), who collectively own approximately 6.2% of the outstanding shares of Oplink Communications Inc. (“Oplink” or the “Company”) (NASDAQ:OPLK), announced today that they have nominated two independent, highly-qualified individuals (the “Nominees”) for election to the board of directors (the “Board”) of Oplink in connection with the upcoming annual meeting of shareholders (the “Meeting”). “Oplink’s announcement of initiatives to enhance shareholder value appears to be a thinly-veiled attempt to placate shareholders who have demanded a thoughtful and comprehensive approach to capital allocation, strategic focus, and meaningful governance reform,” said Glenn W.
Sign-up for Oplink Shareholders for Change (OSC) Nominate Two Highly-Qualified Individuals for Oplink Board investment picks
FREMONT, Calif., June 30, 2014 (GLOBE NEWSWIRE) -- Oplink Communications, Inc. (Nasdaq:OPLK) , a leading provider of optical communication components, intelligent modules and subsystems, today unveiled WiseHome, a family of connected products for smarter living that includes home security, surveillance, safety, automation, and home health.
Sign-up for Oplink Unveils WiseHome: Solutions for Smarter Connected Living investment picks
Opower (NYSE:OPWR), a leading provider of cloud-based software for the utility industry, today announced its financial results for the second quarter ended June 30, 2014.
Sign-up for Opower Announces Second Quarter 2014 Financial Results investment picks
Opower (NYSE: OPWR), a leading provider of cloud-based software to the utility industry, today announced that it will release its second quarter 2014 financial results for the period ended June 30, 2014 after market close on Tuesday, August 12, 2014.
Sign-up for Opower to Announce Second Quarter 2014 Earnings Results on August 12, 2014 investment picks
NEW YORK , June 26, 2014 /PRNewswire/ -- Oppenheimer & Co.
Sign-up for Oppenheimer Concludes Its Fourteenth Annual Consumer Conference In Boston June 24 And 25 investment picks
2014/9/3
http://media.marketwire.com/attachments/201404/237738_237722_JLLLogoFinalArtwork_RGB.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1141472&ProfileId=051205&sourceType=1 CHICAGO, IL and SAN FRANCISCO, CA --
Sign-up for Opportunity for High-Tech Firms Spills Into Suburban Metros, Urban Areas Remain Hot investment picks
2014/7/8
OpSec Security Group plc, a leading supplier of anti-counterfeiting technologies and services, today announced that Richard S.
Sign-up for OpSec Security Group plc Appoints Richard S. Cremona as CEO investment picks
Optibase Ltd.
Sign-up for Optibase Ltd. Announces Second Quarter Results investment picks
2014/7/16
ROANOKE, Va.
Sign-up for Optical Cable Corporation Declares Quarterly Dividend investment picks
2014/9/10
OCC® Achieves Increases in Net Sales, Gross Profit and Net Income ROANOKE, Va.
Sign-up for Optical Cable Corporation Reports Third Quarter 2014 Financial Results investment picks
2014/8/4
AVT customer is grabbing market share in $2 trillion travel and tourism industry CORONA, Calif.
Sign-up for Opticwash is Grand at Emerald Grande investment picks
2010/08/31
The Combine feature in Morningstar.com's Portfolio Manager tool allows investors to create a streamlined view of their assets to help accomplish specific goals.
Sign-up for Optimize Your Portfolios by 'Combining' Them investment picks
ROCHESTER, Mich.
Sign-up for OptimizeRx Corporation Announces Key Updates investment picks
2010/07/08
Working longer and managing spousal benefits are key variables when factoring Social Security into your retirement plan.
Sign-up for Optimizing Social Security: It's More Complicated Than You Think investment picks
2014/8/4
- Sweepstakes Offers Trip for Four to Live Taping of Puppy Bowl XI in NYC - --
Sign-up for Optimum, Animal Planet And Bronx Zoo Want To Send You to Puppy Bowl XI investment picks
FORT LAUDERDALE, Fla., July 3, 2014 (GLOBE NEWSWIRE) -- OptimumBank Holdings, Inc. (Nasdaq:OPHC) , the parent company of OptimumBank ("Company"), announced today that Norman J.
Sign-up for OptimumBank Appoints Norman J. Ginsparg as Director investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE to OptimumBank Appoints Norman J. Ginsparg as Director
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices